Five Prime Therapeutics (FPRX) Tops Q4 EPS by 27c
Tweet
Share
E-mailGet Alerts FPRX Hot Sheet
Join SI Premium – FREE
Five Prime Therapeutics (NASDAQ: FPRX) reported Q4 EPS of ($1.04), $0.27 better than the analyst estimate of ($1.31).
For earnings history and earnings-related data on Five Prime Therapeutics (FPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Freightos Limited (CRGO) Tops Q2 EPS by 3c ; Offers Guidance
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- INVO Fertility (IVF) Tops Q2 EPS by 105c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
